EANM 2024

(90 min) Prof. Ken Herrmann, Head of Nuclear Medicine Department, University Hospital Essen, Germany Join our satellite symposium titled “Shaping the future of the nuclear medicine department”, moderated by Prof. Ken Herrmann, Head of Nuclear Medicine Department, University Essen, Germany

Speaker Bio:
Prof. Dr. Herrmann is Professor of Nuclear Medicine at the Universitätsklinikum Essen, Essen, Germany and until recently acted as Adjunct Professor at the Ahmanson Translational Imaging Division of the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA), Los Angeles, California, USA.​ ​ In 2011, he completed his residency in nuclear medicine at Klinikum rechts der Isar, Technische Universität München, Munich, Germany, focusing on his research entitled “In Vivo Proliferation Imaging with 3´deoxy-3´-[18F]Fluorothymidine PET in... Oncology”. Following this, Prof. Dr Herrmann then went on to complete a fellowship at Hokkaido University, Hokkaido, Japan and received an executive MBA degree from the University of Zürich, Zürich, Switzerland. From 2012 to 2016, he served as Vice Chair of the Department of Nuclear Medicine at Universitätsklinikum Würzburg, Würzburg, Germany.​ Presently, he is Section Editor of The Journal of Nuclear Medicine and Cancer Imaging, and until recently served as Chair of the European Association of Nuclear Medicine (EANM) Oncology & Theranostics Committee. He has also authored more than 700 peer-reviewed articles.​

(90 min) Prof. Francois Rouzet, Head of Nuclear Medicine Department, Bichat Hospital, France


Join our satellite symposium titled “Shaping the future of the nuclear medicine department” and hear a presentation from Prof. Francois Rouzet, titled “Advancing cardiac PET accessibility: the role of novel tracers”. Additionally, Prof. Francois Rouzet will also share his insights as he joins our panel discussion on the future of Molecular Imaging.

Speaker Bio: François Rouzet, MD, PhD is head of the Nuclear Medicine Department at Bichat Hospital (Paris, France), director of the preclinical imaging platform and Professor of Nuclear Medicine and Biophysics at Université Paris Cité. After completing his Medical Degree in Cardiology, he moved to Nuclear Medicine and obtained a PhD in engineering sciences. Since then, his research activities range from preclinical development of imaging agents, cardiovascular hybrid PET/MR, and clinical nuclear imaging. He authored >110 peer-reviewed articles mainly in the domains of myocardial perfusion imaging, cardiac amyloidosis and infective endocarditis. He is involved in many teaching activities in cardiovascular imaging, reviewer for the main journals of cardiology and nuclear medicine and expert for research agencies. He is board member of the French Society of Nuclear Medicine and member of the French National University Council for Nuclear Medicine.

(90 min) Dr. Arthur Braat, M.D. Ph.D., Nuclear Medicine Physician, University Medical Center Utrecht, The Netherlands


Join our satellite symposium titled “Shaping the future of the nuclear medicine department” and hear a presentation from Dr. Arthur Braat, M.D. Ph.D., titled “Advancing cardiac PET accessibility: the role of novel tracers”. Additionally, Dr. Arthur Braat will also share his insights as he joins our panel discussion on the future of Molecular Imaging.

Speaker Bio: Directly after finishing his residency, Dr. Arthur Braat became Nuclear Medicine Physician at the University Medical Center, specialized in radionuclide treatments in general. He finished his PhD-thesis “Hepatic Radioembolization in Neuroendocrine Neoplasms” in 2019. Currently working as a nuclear medicine physician at the University Medical Center Utrecht, Princes Máxima Center (the national center for pediatric oncology) and the Netherlands Cancer Institute in Amsterdam. In 2023, he was appointed as associate professor at the University Utrecht / University Medical Center Utrecht and as advisory board member of the European NeuroEndocrine Tumor Society (ENETS). Special interest in clinical translation of new radiopharmaceuticals for imaging and optimization of radionuclide treatments. He initiates and participates in first-in-man studies, several phase 1, 2, and 3 trials on both diagnostic and therapeutic radiopharmaceuticals for a wide variety of diseases and new administration methods.

(90 min) Prof. Jan Abrahamsen, Head of Nuclear Medicine Department, Regionshospitalet Viborg, Denmark


Join our satellite symposium titled “Shaping the future of the nuclear medicine department” and hear from Prof. Jan Abrahamsen on his experience utilising new technologies to help bring more diagnostic confidence and efficiency to the nuclear medicine department titled “Leveraging new technology to elevate nuclear medicine imaging”. Additionally, Prof. Abrahamsen will also share his insights as he joins our panel discussion on the future of Molecular Imaging.

Speaker Bio: Prof. Jan Abrahamsen is the Head of the Nuclear Medicine Department at Regionshospitalet Viborg, Denmark and a Preclinical associated Professor at the Department of Clinical Medicine, Aarhus University, Denmark. He has authored or co-authored over 50 publications, including those in the Journal of the Danish Medical Association, and has been awarded honourable member of the Danish Society of Clinical Physiology and Nuclear Medicine.

(90 min) Prof. Louise Emmett, Director of Theranostics and Nuclear Medicine, St. Vincent’s Hospital Syndey, Australia


Join our satellite symposium titled “Shaping the future of the nuclear medicine department” and hear Prof. Louise Emmett discuss her experience utilising new technologies to help bring more diagnostic confidence and efficiency to the nuclear medicine department in her presentation titled “Leveraging new technology to elevate nuclear medicine imaging”. Additionally, Prof. Emmett will share her insights during our panel discussion on the future of Molecular Imaging.

(90 min) Prof. Mike Sathekge, CEO and Head of Nuclear Medicine Department, NuMeRI, South Africa


Join our Satellite Symposium titled “Shaping the future of the nuclear medicine department” and hear from Prof. Mike Sathekge, CEO and Head of Nuclear Medicine Department, NuMeRI, South Africa, as he joins our panel discussion on the future of Molecular Imaging.

Speaker Bio: Prof. Mike Sathekge is Professor and Head of Nuclear Medicine department at University of Pretoria and Steve Biko Academic Hospital. He heads the South African Nuclear Medicine Research Infrastructure. Prof Sathekge has published over 220 peer-reviewed articles, excluding abstracts and book chapters. He is one of the global leaders concerning treatment of prostate cancer using targeted radiopharmaceuticals. He also led and introduced several targeted molecular imaging and therapeutic probes in infection and oncology in Africa. Prof. Mike Sathekge is the Editor-in-Chief of Seminars in Nuclear Medicine and an Associate Editor of the European Journal of Nuclear Medicine and Molecular Imaging and the Journal of Nuclear Medicine (leading journals in nuclear medicine). Prof. Mike Sathekge is the President of the World Association of Radiopharmaceuticals and Molecular Therapy, the Past Chair of South African Medical Research Council and Past President of the Colleges of Medicine of South Africa (CMSA). Some of the significant awards include; the award to host the Main Nuclear Medicine Research Infrastructure Facility (NuMeRI) in South Africa, the South African Clinician Society Research Excellence Award, Fellowship in Art and Science of Medicine Award, Ralph Kirsch Golden Pen Award, SAMA Leadership award, the Medical Research Council Prestigious President’s Award for exceptional lifelong contribution to medical research and public health, Prof Mike Sathekge is the chair of the ASSAf panel on research, development and innovation of peaceful uses of nuclear technologies in South Africa. Prof. Mike Sathekge holds the highest honour of the CMSA, Honorary Fellowship and he was also honoured by being admitted as a Fellow of the Academy of Medicine, Singapore.

(90 min) Prof. Irene Burger, Head of Nuclear Medicine Department, Kantonsspital Baden, Switzerland


Join our Satellite Symposium titled “Shaping the future of the nuclear medicine department” and hear from Prof. Irene Burger, Head of Nuclear Medicine Department, Kantonsspital Baden, Switzerland , as she joins our panel discussion on the future of Molecular Imaging.

Speaker Bio: Prof. Dr. med Irene A. Burger, obtained her Medical degree from the University of Zurich 2004, with a thesis analyzing the diagnostic improvement in colorectal cancer with the use of positron emission tomography (PET) combined with computer tomography (CT). She gained her board certifications for radiology and nuclear medicine at the University Hospital of Zurich, followed by a research year in molecular imaging at Memorial Sloan-Kettering Cancer Center (NY). Since March 2015 she received her venia legendi for “Integrated molecular imaging: accurate staging and PET quantification in gynecologic oncology.” Supported by Prof. G. K. von Schulthess and Prof. J. Hodler. 2019 she took over the nuclear medicine department of the Kantonsspital Baden and received the titular professorship of the University of Zurich in 09/22. Overall, she published over 150 peer-reviewed articles, wrote several book chapters and several invited articles and case reports. She could rise a total of over 2.7 Mio CHF for her past and still ongoing research projects, supervised 7 doctoral thesis and 3 PhD at ETH and is an established lecturer at the University of Zurich. 



(90 min) Prof. Andrei Iagaru. ​Professor of Radiology - Nuclear Medicine & Molecular Imaging and board-certified nuclear medicine physician

Join our Satellite Symposium titled “Shaping the future of the nuclear medicine department” and hear from Prof. Andrei Iagaru, Professor of Radiology - Nuclear Medicine & Molecular Imaging and board-certified nuclear medicine physician, as he joins our panel discussion on the future of Molecular Imaging.